Dose Adjustment for Normal Eating (DAFNE) Study

A report published by the Department of Health in 2005 identified the Dose Adjustment for Normal Eating (DAFNE) initiative as the only structured education programme for Type 1 diabetes that met their requirements for a high quality programme. Despite the success of the DAFNE project, important questions remain unanswered. Many patients cannot sustain the approach and in others, glycosylated haemoglobin (HbA1c) is unchanged or worsens after the course (20% of DAFNE graduates have HbA1c >9%). It is unclear which elements are critical to success or whether specific patient characteristics or experiences predict those who do well or poorly. Psychological and sociological expertise will be used in a combined quantitative and qualitative approach to a) establish which components of DAFNE determine success, b) identify predictors of success or ‘failure’, c) learn why some people cannot sustain intensive self-management. Understanding factors which facilitate/impede self-management will help to explain patterns and predictors of successful outcomes not only in type 1 diabetes but will also inform programmes in Type 2 diabetes, such as the DESMOND (Diabetes Education and Self-Management for Ongoing and Newly Diagnosed) programme.

This is a 3-year study involving 250 participants at 12 different hospitals. Recruitment commenced in July 2008. This study is funded through a programme grant awarded by the National Institute for Health Research (NIHR) to Professor Simon Heller at the University of Sheffield, Dr Marie Clark/Prof Andrew Steptoe at UCL, Dr Julia Lawton at Edinburgh University and a number of other applicants. Dr Debbie Cooke is responsible for the day-to-day management of the quantitative component of this study.

For a list of references relating to DAFNE please click here.

Page last modified on 19 may 09 14:09